Eli Lilly and Company (LLY) announced that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1. In addition, the company announced that Karen Walker will transition her role with Lilly, resigning as a member of Lilly’s board of directors effective Dec. 31. In 2025, Walker will collaborate with Lilly on certain digital commercial activities. Moeller is the chairman of the board, president and CEO of Procter & Gamble (PG).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss
- Lilly’s muvalaplin lowered lipoprotein(a) levels in adults in Phase 2 trial
- Eli Lilly sues to change hospital drug discount payments, WSJ reports
- Eli Lilly and Co (NYSE:LLY) Sues Federal Health Agency over Hospital Drug Discounts
- Wolfe sees attractive Eli Lilly opportunity on price drop, starts at Outperform